News

The study did not meet its primary endpoint of a statistically significant reduction in 180-day all-cause mortality although it did produce a slight improvement in mortality rate over

The study, published in the November issue of Cancer Epidemiology Biomarkers & Prevention, was conducted by a team from Johns Hopkins University School of Medicine and Bloomberg School

The studies will evaluate the ability of CTCE-9908 to inhibit the signaling and function of the CXCR4 receptor found on prostate cancer cells. The CXCR4 receptor, present on

The last decade has marked a major improvement in the treatment of HIV positive patients thanks to the highly active anti-retroviral treatment (HAART) consisting of a cocktail of

In this dose-ranging trial, more than 60% of patients with moderately to severely active rheumatoid arthritis (RA) treated with golimumab and methotrexate experienced at least 20% improvement in

Enrollment in the trial, which began in late May 2004, was completed in less than 18 months. The trial is being conducted at 95 neonatal intensive care units

Age-related learning and memory decline in the brain has also been shown to be accompanied by inflammatory changes, typified by microglial activation. These changes are also accompanied and

Under terms of the agreement, Recordati will have the exclusive right to market and sell Labopharm’s product in the UK. Labopharm will provide Recordati with the finished packaged

The models should provide new insights into the processes that cause degeneration of the nervous system in patients with multiple system atrophy, but also as models in which